Untitled Document Rockville, MD (Mar. 6)—The US Pharmacopeial Convention (USP) signed a Memorandum of Understanding (MOU) with the Chinese Pharmacopoeia Commission (ChP) designed to strengthen the quality of medicine and foods in the United States and China. The agreement is a renewal of a prior arrangement that was in place...
Link to Article
Pharmaceutical Technology -- Advanstar Communications Inc.
|
|
||||
|
Thursday, March 13
by
Alex Hsieh on behalf of Professor Henry Wang
on Thu 13 Mar 2008 11:58 PM EDT
by
Lyle
on Thu 13 Mar 2008 10:23 PM EDT
by
Lyle
on Thu 13 Mar 2008 10:19 PM EDT
Indianapolis, IN (Mar. 7)—Eli Lilly terminated the development of its inhaled insulin product AIR, a diabetes treatment that had been in Phase III clinical trials.
Link to Article Pharmaceutical Technology
by
Lyle
on Thu 13 Mar 2008 10:17 PM EDT
Rockville, MD (Mar. 6)—Concerns over contaminated heparin product worsened as US officials announced dialysis patients in Germany have fallen ill after using a different brand of the blood thinner than was already being recalled.
Link to Article Pharmaceutical Technology
by
Lyle
on Thu 13 Mar 2008 10:15 PM EDT
by
Lyle
on Thu 13 Mar 2008 10:13 PM EDT
11-Mar-2008 - The made-in-China heparin scare has now spread beyond the US, with Germany and Japan both recalling the drug.
Link to Article In-Pharmatechnologist.com
by
Lyle
on Thu 13 Mar 2008 10:09 PM EDT
12-Mar-2008 - Politicians in the US have gone on the offensive while regulators and industry groups have circled their wagons over a five-month investigation by the Associated Press that has rung alarm bells about trace levels of pharmaceuticals in drinking water.
Link to Article In-Pharmatechnologist.com
by
Lyle
on Thu 13 Mar 2008 10:08 PM EDT
11-Mar-2008 - The prospects for a viable market in inhaled insulin therapies were looking markedly thinner this week after Eli Lilly pulled the plug on its joint development programme with drug delivery specialist Alkermes for AIR Insulin.
Link to Article In-Pharmatechnologist.com |
Search
Links
|
|||